MAHE releases MET 2021 hall tickets at manipal.edu; check steps to download here

-

The Manipal Academy of Higher Education (MAHE) has released the hall tickets for the Manipal Entrance Test (MET) 2021. Aspirants can download the admit cards by visiting the official website manipal.edu/entrancetest. They can select the shift timings before downloading the hall ticket.

Candidates can follow these steps to download the admit card:

Step 1: Go to the official website manipal.edu/entrancetest

Step 2: Now, log in using the application number and password

Step 3: Select the entrance exam timings

Step 4: Download the admit card and take a print out

Alternatively, this direct link can be used to access hall tickets: https://ift.tt/3scss2Y

MET 2021 is a common entrance test for admission to the B.Tech, BPharma, and DPharma programmes offered by MAHE, Sikkim Manipal Institute of Technology (SMU Sikkim), and Manipal University (MU) Jaipur. After the entrance test, an online BTech Common Counseling Process will be organized for the selected students.

This year, the exam will be held in two phases. The Phase 1 will begin from 16 to 20 April for BTech, BPharma, Dpharma, and postgraduate course MSc Clinical Psychology. While Phase 2 will be held from 9 to 15 June.

Candidates can choose their entrance test city/day/slots in the Online Test Booking System (OTBS) based on the availability of seats. This system is opened 15 days before the commencement of the exam.

The exam duration will be of two hours this year instead of three. There will be 60 multiple-choice questions (MCQ) and numerical-type questions. Out of these, 15 MCQ will be in Mathematics and 10 each in Physics, Chemistry, and English section. Mathematics, Physics, and Chemistry will have five numerical-type questions from each category, as noted by NDTV.



from Firstpost India Latest News https://ift.tt/3s8dL0F
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more